This page has been optimized for print.

GlaxoSmithKline Consumer Healthcare offers free nicotine lozenges for all certified pilots and air traffic controllers to help them safely quit smoking

In response to the announcement by the Federal Aviation Administration (FAA), Commit Lozenges now offered to pilots and air traffic controllers who are quitting smoking

Pittsburgh, Pa · May 23, 2008 /PRNewswire/ — With the Federal Aviation Administration's (FAA) recent announcement to remove a prescription anti-smoking pill from their approved list of safe medications for pilots, GSK Consumer Healthcare, an industry leader in smoking cessation, is offering one free 48 count of 2mg or 4mg Commit Cherry lozenges to all licensed commercial and private pilots who are interested in quitting smoking today, through June 30. It is important for pilots to understand that NRT has been the recommended aid for pilots to quit smoking since 1994, and that the FAA news in no way includes GSK's products, which are deemed safe and effective medicines to relieve nicotine withdrawal symptoms that arise during a quit attempt.

Recent clinical research has demonstrated that the Commit 4 mg lozenge reverses the negative impact that nicotine withdrawal has on the ability to concentrate, attention deficit, short-term memory and selective attention during a quit attempt1 — all these issues were at the core of the FAA's ruling.

"It's important that pilots interested in quitting have access to safe, evidence-based treatments," said Bill Slivka, vice president, Smoking Control, GlaxoSmithKline Consumer Healthcare. "Over the past ten years, our NRT products, including the Commit lozenge, have helped more than 6.5 million smokers around the world quit. This free offer to pilots and air traffic controllers further demonstrates our mission to help more smokers achieve their goal of safely becoming smoke-free."

The Commit lozenge give-away program is open to all U.S. residents, 18 years of age or older, with a valid certification. Pilots and air traffic controllers meeting the aforementioned criteria can call 1.877.NO.ASHES, or 1.877.662.7437 to request one free 48 count of 2mg or 4mg Cherry Commit lozenges, and also gain access to smoking cessation counselors. The line is open from 8 a.m. — 9 p.m. EDT, Monday through Friday (no weekends or holidays). During Memorial Day weekend, the line will be open from 12-4 p.m. EDT, Saturday and Sunday. GlaxoSmithKline Consumer Healthcare will also pay shipping and handling costs.

Smoking remains one of the leading causes of preventable death and disease and one of the most powerful and important addictions to break. That said, many smokers can't do it alone. Evidence-based treatments such as NRT, including the Commit lozenge, in combination with counseling offer a better chance of quitting versus cold turkey.2 More than 110 studies involving approximately 40,000 smokers have demonstrated the safety of NRT even in populations with specific health conditions, such as diabetes, high blood pressure, lung disease, and existing heart disease.3

About The Give-Away

GSK Consumer Healthcare is offering to help pilots interested in quitting get started on a path to a smoke-free life. The give-away begins on Friday, May 23rd and goes through Monday, June 30th. All U.S. residents, 18 years of age or older, with a valid pilot certification are eligible. The offer is on a first come, first serve basis while supplies last. Pilots meeting the aforementioned criteria can call 1.877.NOASHES, or 1.877.662.7437. The line is open from 8 a.m. — 9 p.m. EDT, Monday through Friday (no weekends or holidays). During Memorial Day weekend, the line will be open from 12-4 p.m. EDT, Saturday and Sunday. A 48 count of 2mg or 4mg Cherry Commit lozenges is being offered as part of this promotion (subject to change without notice). Each person will have access to smoking cessation counselors through 1.877.NO.ASHES.

About the Commit Lozenge

Commit is approved by the FDA to help control tough cravings associated with quitting smoking.4 Commit has a unique dosage selector based on how soon a smoker smokes his first cigarette in the morning, so he can choose the strength that's right for him. The Commit lozenge helps people stop smoking by providing low, safe doses of NRT to ease withdrawal from cigarettes. Commit comes in different strengths—2 mg or 4 mg—to be used depending on how soon a smoker has his first cigarette in the morning. The 2 mg dosage is for smokers who usually have their first cigarette more than thirty minutes after waking up. The 4 mg dosage is for smokers who usually have their first cigarette within thirty minutes of waking up.

About GlaxoSmithKline Consumer Healthcare

GSK Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. GSK offers the widest range of proven NRT products available, products which can significantly improve a smoker's chance of quitting successfully and have helped millions of people quit smoking. In addition, GSK offers several resources and support services designed specifically to help smokers and non-smokers understand and address the two components to smoking cessation: nicotine addiction and habit change. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette®, NicoDerm® CQ and Commit® as well as many medicine cabinet staples, including Abreva®, alli® Aquafresh®, Sensodyne®, Tums® and Breathe Right®, trademarks owned and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and consumer healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

1 GSK Data on file, Study S2540345 report Boyle et al 2006.
2Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD:
3Stead LF, Perera R, Bullen C,Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD000146. DOI: 10.1002/14651858.CD000146.pub3.
4FDA labeling for gum/lozenge/patch. 2005. Labels on boxes of Nicorette, Commit and NicoDerm CQ